Kawasaki Syndrome
Basics
Description
- Kawasaki syndrome (KS) is a self-limited acute, febrile, systemic vasculitis of small- and medium-sized arteries that predominantly affects patients aged 6 months to 5 years.
- The most prominent cause of acquired coronary artery disease in children in developed countries (1)
- Vasculitis of coronary arteries results in aneurysms/ectasia, myocardial infarction (MI)/ischemia, or sudden death.
- System(s) affected: cardiovascular, gastrointestinal, hematologic/lymphatic/immunologic, musculoskeletal, nervous, pulmonary, renal/urologic, skin/exocrine
- Synonym(s): mucocutaneous lymph node syndrome (MCLS), infantile polyarteritis, Kawasaki disease
ALERT
Consider in any child with extended high fever unresponsive to antibiotics or antipyretics, rash, and nonexudative conjunctivitis.
Consider in any child with extended high fever unresponsive to antibiotics or antipyretics, rash, and nonexudative conjunctivitis.
Epidemiology
Incidence
- Worldwide: affects all races but most prevalent in Asia; Japan annual incidence rate of 265/100,000 in children <5 years old
- In the United States, annual incidence in children aged <5 years is 20/100,000. Compared to white people, African Americans have 1.5 times risk, and Asian Americans have 2.5 times risk. The highest state incidence is in Hawaii.
- Leading cause of acquired heart disease in children in developed countries
- Predominant age: 1 to 5 years; median age of diagnosis is 1.5 years of age.
- 85% of cases are children <5 years of age and 50% <2 years of age.
- Male-to-female ratio = 1.5:1
Prevalence
- Highest to lowest prevalence: Asian > African American > Hispanic > white
- Seasonal variation: peaks in winter and early spring (January to March) in temperate places; peaks in summer in Asia
- Outbreaks at 2- to 3-year intervals
Etiology and Pathophysiology
- Infectious agent triggers abnormal inflammatory reaction in children with genetic predisposition.
- Acute KS causes a necrotizing arteritis in the smooth muscle layer of medium extraparenchymal arteries, destroying arterial walls into the adventitia, especially in coronary arteries.
- Inflammatory cells secrete cytokines (TNF-α), interleukins 1 and 6, and matrix metalloproteases that cause fragmentation of the internal elastic lamina
- As the acute process resolves, active neutrophilic inflammatory cells are succeeded by a subacute/chronic, lymphocytic vasculitis; fibroblasts and monocytes cause tissue repair/remodeling that may cause vascular fibrosis and stenosis.
Genetics
- Populations at higher risk and family link suggest a genetic predisposition.
- Siblings of patients in Japan have a 10- to 30-fold increased risk, and >50% develop KS within 10 days of first case; increased occurrence of KS in children whose parents also had illness in childhood
- Single-nucleotide polymorphisms in six different genes have been implicated in KS (Fcγ receptor 2A, CASP3, HLA class II, B-cell lymphoid kinase, IPTKC, CD40).
- Coronary aneurisms are associated with variants in TGF-β signaling pathways.
Risk Factors
- Male to female prevalence 1.5:1 in the United States
- African Americans at 1.5 times risk; Asian Americans at 2.5 times risk
- Sibling with Kawasaki
General Prevention
None
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Domino, Frank J., et al., editors. "Kawasaki Syndrome." 5-Minute Clinical Consult, 33rd ed., Wolters Kluwer, 2025. Medicine Central, im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/116332/all/Kawasaki_Syndrome.
Kawasaki Syndrome. In: Domino FJF, Baldor RAR, Golding JJ, et al, eds. 5-Minute Clinical Consult. Wolters Kluwer; 2025. https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/116332/all/Kawasaki_Syndrome. Accessed November 18, 2024.
Kawasaki Syndrome. (2025). In Domino, F. J., Baldor, R. A., Golding, J., & Stephens, M. B. (Eds.), 5-Minute Clinical Consult (33rd ed.). Wolters Kluwer. https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/116332/all/Kawasaki_Syndrome
Kawasaki Syndrome [Internet]. In: Domino FJF, Baldor RAR, Golding JJ, Stephens MBM, editors. 5-Minute Clinical Consult. Wolters Kluwer; 2025. [cited 2024 November 18]. Available from: https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/116332/all/Kawasaki_Syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Kawasaki Syndrome
ID - 116332
ED - Domino,Frank J,
ED - Baldor,Robert A,
ED - Golding,Jeremy,
ED - Stephens,Mark B,
BT - 5-Minute Clinical Consult, Updating
UR - https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/116332/all/Kawasaki_Syndrome
PB - Wolters Kluwer
ET - 33
DB - Medicine Central
DP - Unbound Medicine
ER -